Journey, the leading provider of proactive mental health solutions for modern companies, announced the closing of its $8 million Series A funding round. The round was led by Cambrian Growth Partners with participation from ManchesterStory, Canaan Partners, J-Ventures, J-Impact, Life Science Angels, HealthTech Capital, and others.
Mental health has become a business-critical priority, but most Employee Assistance Programs (EAPs) are outdated, reactive, and underused. Journey is changing that with the first Proactive EAP: a platform embedded into the rhythm of daily work, personalized to each employee, and accessible globally. With an employee engagement rate that is 10x the industry average, Journey helps companies deliver real support with measurable results.
“This funding allows us to scale a vision we believe in deeply,” said Stephen Sokoler, Founder and CEO of Journey. “The future of workplace mental health is proactive—meeting people where they are, before things escalate, and providing meaningful, human-centered support that people actually use.”
Traditional EAPs have low engagement, slow time to care, and limited clinical outcomes. They were built for crisis response, not daily support—and it shows in their 3% average utilization and employee dissatisfaction.
Existing EAPs—whether traditional or digital—wait until someone raises their hand. But by then, it’s often too late. Employees suffer in silence, delay care, or never reach out at all. Issues escalate, and businesses pay the price through lost productivity, absenteeism, and rising healthcare costs.
Also Read: Fable Security Launches With $31M to Stop Risky Human Behavior
Journey does things differently. As the first Proactive EAP, it reaches out first—engaging early, identifying warning signs, and stepping in before issues escalate. With over 30% employee engagement, Journey delivers personalized care at a fraction of the cost of digital EAPs and drives real business outcomes.
“Journey is transforming how companies support mental health—moving from reactive, check-the-box solutions to proactive, high-impact care,” said Richard Goozh, Managing Partner at Cambrian Growth Partners. “We’re proud to back a team delivering global, outcomes-driven support that companies trust and employees value.”
This investment marks a major step forward for Journey, enabling the company drive further innovation across its platform and enable more personalized care at scale. Through smarter AI and meaningful partnerships with mission-aligned employers and consultants, Journey is scaling its impact across the U.S. and globally.
“Journey is tackling one of the most urgent and complex challenges facing modern companies,” said Brendan Dickinson, General Partner at Canaan Partners and Board Member at Journey. “The team is moving fast, executing with purpose, and driving meaningful impact at scale.”
Journey currently supports millions of employees across industries—including tech, healthcare, finance, education, manufacturing, and retail. Clients include Universal Music Group, FactSet, Micron, BD, Regeneron, New Balance, and Georgetown University.
“We’re a science company, driven by data and analytics. We want the same from our partners. Journey came to us with numbers that made it easy to say yes — and they continue to back it up,” said Meredith Marlin, VP of Total Rewards at Regeneron.
“Companies are done checking a box—they want real impact,” added Sokoler. “Journey will use this capital to further develop our AI-powered platform, expand global clinical access, and accelerate partnerships with employers and consultants seeking higher mental health engagement at scale.”
Source: Einpresswire
